The stock market has experienced significant gains in 2024, with the FTSE 100 up 12% and the S&P 500 soaring 30%. Analysts predict continued growth in 2025, with the FTSE 100 potentially nearing 10,000 and the S&P 500 reaching 6,666, driven by expected GDP growth. Investors are advised to consider small- and mid-cap companies, particularly Bioventix, which shows promise in the biotech sector amid rising demand for its Alzheimer’s detection solutions.